Practical recommendations for screening of information on the drug safety

Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attra...

Full description

Bibliographic Details
Main Authors: E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov
Format: Article
Language:Russian
Published: Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation  2018-02-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/52
id doaj-2fe145d68db34332b4155f97f53a50dc
record_format Article
spelling doaj-2fe145d68db34332b4155f97f53a50dc2021-07-28T14:03:05ZrusFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation Безопасность и риск фармакотерапии2312-78212619-11642018-02-0103363952Practical recommendations for screening of information on the drug safetyE. Yu. Pasternak0T. M. Bukatina1R. N. Alyautdin2B. K. Romanov3Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsActive development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attracted to the problem of drug safety the attention of practitioners and other health professionals. This article presents practical recommendations on possible sources for screening of information on the drug safety, which can operate in their activity as health professionals.https://www.risksafety.ru/jour/article/view/52фармаконадзорлекарственное средствомониторинг безопасности лекарственных средствисточники информации о безопасности лекарственных препаратовpharmacovigilancedrugdrug safety monitoringinformational sources
collection DOAJ
language Russian
format Article
sources DOAJ
author E. Yu. Pasternak
T. M. Bukatina
R. N. Alyautdin
B. K. Romanov
spellingShingle E. Yu. Pasternak
T. M. Bukatina
R. N. Alyautdin
B. K. Romanov
Practical recommendations for screening of information on the drug safety
Безопасность и риск фармакотерапии
фармаконадзор
лекарственное средство
мониторинг безопасности лекарственных средств
источники информации о безопасности лекарственных препаратов
pharmacovigilance
drug
drug safety monitoring
informational sources
author_facet E. Yu. Pasternak
T. M. Bukatina
R. N. Alyautdin
B. K. Romanov
author_sort E. Yu. Pasternak
title Practical recommendations for screening of information on the drug safety
title_short Practical recommendations for screening of information on the drug safety
title_full Practical recommendations for screening of information on the drug safety
title_fullStr Practical recommendations for screening of information on the drug safety
title_full_unstemmed Practical recommendations for screening of information on the drug safety
title_sort practical recommendations for screening of information on the drug safety
publisher Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation 
series Безопасность и риск фармакотерапии
issn 2312-7821
2619-1164
publishDate 2018-02-01
description Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attracted to the problem of drug safety the attention of practitioners and other health professionals. This article presents practical recommendations on possible sources for screening of information on the drug safety, which can operate in their activity as health professionals.
topic фармаконадзор
лекарственное средство
мониторинг безопасности лекарственных средств
источники информации о безопасности лекарственных препаратов
pharmacovigilance
drug
drug safety monitoring
informational sources
url https://www.risksafety.ru/jour/article/view/52
work_keys_str_mv AT eyupasternak practicalrecommendationsforscreeningofinformationonthedrugsafety
AT tmbukatina practicalrecommendationsforscreeningofinformationonthedrugsafety
AT rnalyautdin practicalrecommendationsforscreeningofinformationonthedrugsafety
AT bkromanov practicalrecommendationsforscreeningofinformationonthedrugsafety
_version_ 1721268780291588096